370 related articles for article (PubMed ID: 32351486)
1. Tuning the Orchestra: HCMV vs. Innate Immunity.
Dell'Oste V; Biolatti M; Galitska G; Griffante G; Gugliesi F; Pasquero S; Zingoni A; Cerboni C; De Andrea M
Front Microbiol; 2020; 11():661. PubMed ID: 32351486
[TBL] [Abstract][Full Text] [Related]
2. Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.
Fu YZ; Su S; Zou HM; Guo Y; Wang SY; Li S; Luo MH; Wang YY
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867312
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses.
Wu Z; Sinzger C; Reichel JJ; Just M; Mertens T
J Virol; 2015 Mar; 89(5):2906-17. PubMed ID: 25540381
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
[TBL] [Abstract][Full Text] [Related]
5. The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.
Dassa L; Seidel E; Oiknine-Djian E; Yamin R; Wolf DG; Le-Trilling VTK; Mandelboim O
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950412
[TBL] [Abstract][Full Text] [Related]
6. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the innate immune response by human cytomegalovirus.
Biolatti M; Gugliesi F; Dell'Oste V; Landolfo S
Infect Genet Evol; 2018 Oct; 64():105-114. PubMed ID: 29935337
[TBL] [Abstract][Full Text] [Related]
8. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
9. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.
Riou R; Bressollette-Bodin C; Boutoille D; Gagne K; Rodallec A; Lefebvre M; Raffi F; Senitzer D; Imbert-Marcille BM; Retière C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031361
[TBL] [Abstract][Full Text] [Related]
10. Hcmv-miR-UL112 attenuates NK cell activity by inhibition type I interferon secretion.
Huang Y; Chen D; He J; Cai J; Shen K; Liu X; Yang X; Xu L
Immunol Lett; 2015 Feb; 163(2):151-6. PubMed ID: 25530545
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
Weisblum Y; Oiknine-Djian E; Zakay-Rones Z; Vorontsov O; Haimov-Kochman R; Nevo Y; Stockheim D; Yagel S; Panet A; Wolf DG
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956761
[TBL] [Abstract][Full Text] [Related]
14. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.
Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358
[TBL] [Abstract][Full Text] [Related]
15. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.
Manandhar T; Hò GT; Pump WC; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344940
[TBL] [Abstract][Full Text] [Related]
16. The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion.
Biolatti M; Dell'Oste V; De Andrea M; Landolfo S
New Microbiol; 2018 Apr; 41(2):87-94. PubMed ID: 29384558
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.
Landolfo S; De Andrea M; Dell'Oste V; Gugliesi F
World J Virol; 2016 Aug; 5(3):87-96. PubMed ID: 27563536
[TBL] [Abstract][Full Text] [Related]
18. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
López-Botet M; Muntasell A; Vilches C
Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761
[TBL] [Abstract][Full Text] [Related]
19. U
Goodwin CM; Schafer X; Munger J
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
[TBL] [Abstract][Full Text] [Related]
20. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
Cederarv M; Söderberg-Nauclér C; Odeberg J
Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
